These results show that HSP70 failure supports endothelial dysfunction in these cells, suggesting that this chaperone may orchestrate a new pathophysiological pathway in CTEPH disease and highlight HSP70 as a new potential biomarker. The gene discussed is HSPA1A; the disease is chronic thromboembolic pulmonary hypertension.